融合-话题@MedSci

#融合#

253篇内容 | 4124人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1525534, encodeId=86db152553448, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Lancet oncol：Pemigatinib可有效治疗携带FGFR2融合或重排的胆管癌, objectType=article, longId=191608, objectId=8be819160868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8be819160868, replyNumber=0, likeNumber=75, createdTime=2020-04-08, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8be819160868, moduleTitle=Lancet oncol：Pemigatinib可有效治疗携带FGFR2融合或重排的胆管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8be819160868)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525533, encodeId=45cb152553313, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=小知识：有关单抗与抗体融合蛋白的差别, objectType=article, longId=190916, objectId=ff721909164b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff721909164b, replyNumber=0, likeNumber=33, createdTime=2020-03-28, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff721909164b, moduleTitle=小知识：有关单抗与抗体融合蛋白的差别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff721909164b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525532, encodeId=abd51525532a5, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Prostate Cancer P D：多参MRI超声融合活检检测前列腺癌的种族差异 , objectType=article, longId=190898, objectId=e6dd190898e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6dd190898e5, replyNumber=0, likeNumber=79, createdTime=2020-03-28, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6dd190898e5, moduleTitle=Prostate Cancer P D：多参MRI超声融合活检检测前列腺癌的种族差异 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6dd190898e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525531, encodeId=73ae15255310e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=上颌融合磨牙根管治疗1例报告, objectType=article, longId=190482, objectId=dd5019048216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd5019048216, replyNumber=0, likeNumber=101, createdTime=2020-03-22, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd5019048216, moduleTitle=上颌融合磨牙根管治疗1例报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd5019048216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525530, encodeId=d3431525530c9, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Lancet Oncol：Larotrectinib治疗TRK融合阳性晚期实体瘤, objectType=article, longId=189095, objectId=34b1189095d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34b1189095d4, replyNumber=0, likeNumber=58, createdTime=2020-03-03, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34b1189095d4, moduleTitle=Lancet Oncol：Larotrectinib治疗TRK融合阳性晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34b1189095d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525529, encodeId=98d5152552932, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Sci Rep：ABO血型不融合肾移植肾移植中选择性血浆置换研究, objectType=article, longId=187740, objectId=d3d718e74061, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3d718e74061, replyNumber=0, likeNumber=68, createdTime=2020-02-11, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3d718e74061, moduleTitle=Sci Rep：ABO血型不融合肾移植肾移植中选择性血浆置换研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3d718e74061)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525528, encodeId=99e71525528f7, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=ARCH PATHOL LAB MED：新一代RNA测序分析用于融合转录和致癌亚型的多重检测, objectType=article, longId=187685, objectId=339c18e6855b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=339c18e6855b, replyNumber=0, likeNumber=73, createdTime=2020-02-09, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=339c18e6855b, moduleTitle=ARCH PATHOL LAB MED：新一代RNA测序分析用于融合转录和致癌亚型的多重检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=339c18e6855b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525527, encodeId=745c152552e35, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Prostate Cancer P D：经会阴和经直肠MRI-US融合活检在前列腺癌检测中的准确性研究, objectType=article, longId=186876, objectId=127c1868e627, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=127c1868e627, replyNumber=0, likeNumber=88, createdTime=2020-01-30, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=127c1868e627, moduleTitle=Prostate Cancer P D：经会阴和经直肠MRI-US融合活检在前列腺癌检测中的准确性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=127c1868e627)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525526, encodeId=c86715255260c, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Clin Chem：突破！RNA+DNA同时测序，检测癌症组织中的基因融合和碱基突变！, objectType=article, longId=184591, objectId=fa6318459181, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa6318459181, replyNumber=0, likeNumber=112, createdTime=2019-12-13, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa6318459181, moduleTitle=Clin Chem：突破！RNA+DNA同时测序，检测癌症组织中的基因融合和碱基突变！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa6318459181)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525525, encodeId=f90415255254d, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=“驯服猛兽”——AI已与医疗深度融合, objectType=article, longId=182119, objectId=b7461821199a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7461821199a, replyNumber=0, likeNumber=78, createdTime=2019-10-31, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7461821199a, moduleTitle=“驯服猛兽”——AI已与医疗深度融合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7461821199a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525524, encodeId=ad5d152552493, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=青少年特发性脊柱侧凸后路矫形融合手术加速康复外科实施流程专家共识, objectType=article, longId=181853, objectId=6a141818530d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a141818530d, replyNumber=0, likeNumber=49, createdTime=2019-10-25, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a141818530d, moduleTitle=青少年特发性脊柱侧凸后路矫形融合手术加速康复外科实施流程专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a141818530d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525523, encodeId=da9515255234e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=智慧医院：从信息化起步，互联网化变身，智慧化融合, objectType=article, longId=180443, objectId=5d941804432e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d941804432e, replyNumber=0, likeNumber=70, createdTime=2019-10-04, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d941804432e, moduleTitle=智慧医院：从信息化起步，互联网化变身，智慧化融合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d941804432e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525522, encodeId=63541525522eb, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者, objectType=article, longId=180106, objectId=b99c180106aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b99c180106aa, replyNumber=0, likeNumber=61, createdTime=2019-09-28, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b99c180106aa, moduleTitle=拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b99c180106aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525521, encodeId=10a4152552120, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Xp11.2易位/TFE3基因融合相关性肾癌1例, objectType=article, longId=179854, objectId=4f771e985478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f771e985478, replyNumber=0, likeNumber=99, createdTime=2019-09-24, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f771e985478, moduleTitle=Xp11.2易位/TFE3基因融合相关性肾癌1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f771e985478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525520, encodeId=e77e152552023, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=融合自然与科技，绿叶医疗集团与克利夫兰医学中心联合在沪打造未来医院, objectType=article, longId=179792, objectId=67cf1e979257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67cf1e979257, replyNumber=0, likeNumber=75, createdTime=2019-09-22, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67cf1e979257, moduleTitle=融合自然与科技，绿叶医疗集团与克利夫兰医学中心联合在沪打造未来医院, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67cf1e979257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525519, encodeId=5e4d1525519c8, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=成人先天性上尺桡关节融合截骨矫形1例, objectType=article, longId=179345, objectId=053f1e93455a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=053f1e93455a, replyNumber=0, likeNumber=81, createdTime=2019-09-14, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=053f1e93455a, moduleTitle=成人先天性上尺桡关节融合截骨矫形1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=053f1e93455a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525518, encodeId=21781525518b8, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=布局建设20个左右试验区推动医疗等与人工智能融合发展, objectType=article, longId=179064, objectId=9a241e9064d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a241e9064d7, replyNumber=0, likeNumber=72, createdTime=2019-09-08, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a241e9064d7, moduleTitle=布局建设20个左右试验区推动医疗等与人工智能融合发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a241e9064d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525517, encodeId=7e56152551e03, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=NRG1融合是极具前景的肿瘤治疗新靶点, objectType=article, longId=178637, objectId=16661e863734, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16661e863734, replyNumber=0, likeNumber=70, createdTime=2019-09-04, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16661e863734, moduleTitle=NRG1融合是极具前景的肿瘤治疗新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16661e863734)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525516, encodeId=296815255164a, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=罗氏的ALK抑制剂Rozlytrek获得FDA批准治疗NTRK基因融合实体瘤和ROS1阳性NSCLC, objectType=article, longId=177801, objectId=78401e780141, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78401e780141, replyNumber=0, likeNumber=66, createdTime=2019-08-18, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78401e780141, moduleTitle=罗氏的ALK抑制剂Rozlytrek获得FDA批准治疗NTRK基因融合实体瘤和ROS1阳性NSCLC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78401e780141)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525515, encodeId=a32715255154e, content=<a href='/topic/show?id=08548885835' target=_blank style='color:#2F92EE;'>#融合#</a>, objectTitle=Am J Transl Res：可溶性骨形态发生蛋白1A型受体融合蛋白治疗可预防糖皮质激素诱导的骨丢失, objectType=article, longId=177527, objectId=b4971e752749, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4971e752749, replyNumber=0, likeNumber=55, createdTime=2019-08-14, rootId=0, userName=licz0427, userId=08a911636812, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4971e752749, moduleTitle=Am J Transl Res：可溶性骨形态发生蛋白1A型受体融合蛋白治疗可预防糖皮质激素诱导的骨丢失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4971e752749)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

融合

2020-05-29

licz0427 (审核中...)

前往app查看评论内容

#融合#

Lancet oncol：Pemigatinib可有效治疗携带FGFR2融合或重排的胆管癌

2020-04-08

licz0427 (审核中...)

前往app查看评论内容

#融合#

小知识：有关单抗与抗体融合蛋白的差别

2020-03-28

licz0427 (审核中...)

前往app查看评论内容

#融合#

Prostate Cancer P D：多参MRI超声融合活检检测前列腺癌的种族差异

2020-03-28

licz0427 (审核中...)

前往app查看评论内容

#融合#

上颌融合磨牙根管治疗1例报告

2020-03-22

licz0427 (审核中...)

前往app查看评论内容

#融合#

Lancet Oncol：Larotrectinib治疗TRK融合阳性晚期实体瘤

2020-03-03

licz0427 (审核中...)

前往app查看评论内容

#融合#

Sci Rep：ABO血型不融合肾移植肾移植中选择性血浆置换研究

2020-02-11

licz0427 (审核中...)

前往app查看评论内容

#融合#

ARCH PATHOL LAB MED：新一代RNA测序分析用于融合转录和致癌亚型的多重检测

2020-02-09

licz0427 (审核中...)

前往app查看评论内容

#融合#

Prostate Cancer P D：经会阴和经直肠MRI-US融合活检在前列腺癌检测中的准确性研究

2020-01-30

licz0427 (审核中...)

前往app查看评论内容

#融合#

Clin Chem：突破！RNA+DNA同时测序，检测癌症组织中的基因融合和碱基突变！

2019-12-13

licz0427 (审核中...)

前往app查看评论内容

#融合#

“驯服猛兽”——AI已与医疗深度融合

2019-10-31

licz0427 (审核中...)

前往app查看评论内容

#融合#

青少年特发性脊柱侧凸后路矫形融合手术加速康复外科实施流程专家共识

2019-10-25

licz0427 (审核中...)

前往app查看评论内容

#融合#

智慧医院：从信息化起步，互联网化变身，智慧化融合

2019-10-04

licz0427 (审核中...)

前往app查看评论内容

#融合#

拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者

2019-09-28

licz0427 (审核中...)

前往app查看评论内容

#融合#

Xp11.2易位/TFE3基因融合相关性肾癌1例

2019-09-24

licz0427 (审核中...)

前往app查看评论内容

#融合#

融合自然与科技，绿叶医疗集团与克利夫兰医学中心联合在沪打造未来医院

2019-09-22

licz0427 (审核中...)

前往app查看评论内容

#融合#

成人先天性上尺桡关节融合截骨矫形1例

2019-09-14

licz0427 (审核中...)

前往app查看评论内容

#融合#

布局建设20个左右试验区推动医疗等与人工智能融合发展

2019-09-08

licz0427 (审核中...)

前往app查看评论内容

#融合#

NRG1融合是极具前景的肿瘤治疗新靶点

2019-09-04

licz0427 (审核中...)

前往app查看评论内容

#融合#

罗氏的ALK抑制剂Rozlytrek获得FDA批准治疗NTRK基因融合实体瘤和ROS1阳性NSCLC

2019-08-18

licz0427 (审核中...)

前往app查看评论内容

#融合#

Am J Transl Res：可溶性骨形态发生蛋白1A型受体融合蛋白治疗可预防糖皮质激素诱导的骨丢失

2019-08-14

科室
- - 订阅+
  - 更多科室
工具
服务